US 10793563
GCN2 inhibitors and uses thereof
granted A61PA61P35/00
Quick answer
US patent 10793563 (GCN2 inhibitors and uses thereof) held by Vertex Pharmaceuticals Incorporated expires Mon Oct 01 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Vertex Pharmaceuticals Incorporated
- Grant date
- Tue Oct 06 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 01 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 28
- CPC classes
- A61P, A61P35/00